Clinical Trial Update: ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares one week versus four weeks of heparin prophylaxis after laparoscopic colorectal cancer surgery to evaluate differences in veno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Heparin (unfractionated heparin)

Snippet

Sponsor: University Of Perugia | Conditions: The Primary Study Objective is to Assess the Efficacy and, Safety of Extended 4-week Heparin Prophylaxis Compared to | Phase 3 | Status: UNKNOWN